Bacteriological and therapeutic profile of diabetic foot infection: a prospective study of 100 patients

##plugins.themes.academic_pro.article.sidebar##

Published Jul 29, 2016
Download
pdf
Vol. 94 No. 2 (2016): Issue Feb 2016

##plugins.themes.academic_pro.article.main##

Mohamed Ben Moussa
Mehdi Khalfallah
Boutiba Ben Boubaker
Ramzi Nouira
Amine Slim
Hichem Jerraya
Chadli Dziri
Ilhem Boutiba Ben Boubaker
Ramzi Nouira
Amine Slim
Hichem Jerraya
Chadli Dziri

Abstract

Summary
Introduction: Identifying the infecting bacterial flora is one of the main rules to be followed to ensure the success of antibiotherapy in the treatment of the infected diabetic foot.
The aim of the work was to define the bacteriological profile of the bacteria causing the infection of the diabetic foot at the surgery unit B of Charles Nicolle’s hospital in Tunis and determine the prognostic factors of this condition.
Methods: It was an open prospective study. It concerned 100 diabetic patients operated on for diabetic foot infection. All patients had bacteriological samples taken through deep scraping and swabing carried out in the operating room.
Results: The average age of patients was 59,5 ±11 years, with a sex-ratio of 2,4. The foot infection was represented in 82 % of cases by a wet gangrene. The enterobacteria were the most frequently isolated bacteria (73%), followed by streptococcus (10%), Staphylococcus aureus (9%). The rate of multidrug-resistant bacteria was of 9,5%. The empiric antibiotic therapy used (fusidic acid +amoxicillin/ clavulanic acid) was inactiveon 44,1% of the isolated bacteria. When we compared the group of patients with unfavourable development (who have been reoperated) and the group of patients with favourable development, we have found two poor prognosis factors : arteritis  (p=0,018 ; OR=23,7) and presence of multidrug-resistant bacteria (p=0,027 ; OR=5,8).
Conclusion: The enterobacteria were the main bacteria causing the infection of diabetic foot. The prognostic factors found, arteritis and isolation of multidrug-resistant bacteria, outpoint the importance of multidisciplinary care.

Keywords:

diabetic foot, infection, bacterium, bacterial resistance, prognostic factors

##plugins.themes.academic_pro.article.details##

References

  1. Toumi A, Bernard L, Chakroun M. Antibiothérapie des infections du pied diabétique. RevTunInfectiol 2011;5:61-7.
  2. Ha Van G, Hartemann-Heurtier A, Gautier F et al. Pied diabétique. Encycl Med Chir Endocrinologie-Nutrition 2011; 10:366-9.
  3. Ben Khalifa A. Le pied diabétique: Expérience du service de Diabétologie Hôpital la Rabta. Tunis Med 1997;75:15-22
  4. Malgrange D. Physiopathologie du pied diabétique. Rev Med Interne 2008;29:231-7.
  5. Richard JL, Sotto A, Lavigne JP. New insights in diabetic foot infection.World J Diabetes 2011;2:24-32.
  6. Comité de l'antibiogramme de la Société Française de Microbiologie. Recommandations 2011. Edition 2011:3-55.
  7. Zubair M, Malik A, Ahmad J. Clinico-microbiological study and antimicrobial drug resistance profile of diabetic foot infections in North India. Foot 2011; 21:6-14.
  8. Gadepalli RB, Dhawan B, Sreenivas V et al. A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care 2006;29:1727-32
  9. Shankar EM, Mohan V, Premalatha G et al. Bacterial etiology of diabetic foot infections in South India. Eur J Intern Med 2005; 16:567-70.
  10. Chang A, Eslao E, Panilagao G, Quimpo J. Diabetic foot ulcers: experience at the Philippine general hospital. Phil J Intern Med 1996;34:205-9.
  11. Tiwari S, Pratyush DD, Dwivedi A et al. Microbiological and clinical characteristics of diabetic foot infections in northern India.J Infect Dev Ctries 2012;6:329-32.
  12. Zubair M, Malik A, Ahmad J. Clinico-bacteriology and risk factors for the diabetic foot infection with multidrug resistant microorganisms in North India. Biol Med 2010;2:22-34.
  13. Parvez N, Dutta P, Ray P et al. Microbial profile and utility of soft tissue, pus, and bone cultures in diagnosing diabetic foot infections. Diabetes TechnolTher 2012;14:669-75.
  14. Citron DM, Goldstein EJ, Merriam CV et al. Bacteriology of Moderate-to-Severe Diabetic Foot Infections and In vitro Activity of Antimicrobial Agents. J ClinMicrobiol 2007;45:2819-28
  15. Dang CN, Prasad YD, Boulton AJ, Jude EB. Methicillin resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med 2003;20:159-61.
  16. Lipsky BA, Berendt AR, Deery HG et al. Diagnosis and Treatment of Diabetic Foot Infections. Clin Infect Dis 2004; 39:885-910.
  17. Yoga R, Khairul A, Sunita K, Suresh C. Bacteriology of diabetic foot lesions. Med J Malaysia 2006;61:14-6.
  18. Prasad KN, Prasad N, Gupta A et al. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: a single centre Indian experience. J Infect 2004;48:96-101
  19. Edmonds M. The treatment of diabetic foot infections: focus on ertapenem. Vas Health Risk Manag 2009;5:949-63.
  20. Lipsky BA. A report from the international consensus on diagnosing and treating the infected diabetic foot. Diabetes Metab Res Rev 2004;20:68-77.
  21. Al Benwan K, Al Mulla A, Rotimi VO. A study of the microbiology of diabetic foot infections in a teaching hospital in Kuwait. J Infect Public Health 2012;5:1-8.
  22. Mutluoglu M, Uzun G. Pseudomonas infection in a postoperative foot wound. CMAJ 2011;17:183-8.
  23. Hartemann-Heurtier A, Robert J, Jacqueminet Set al. Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact. Diabet Med 2004;21:710-5
  24. Zubair M, Malik A, Ahmad J. Study of Plasmid-Mediated Extended-Spectrum β Lactamase-Producing Strains of Enterobacteriaceae isolated from Diabetic Foot infections in a North Indian Tertiary-Care Hospital. Diabetes TechnolTher 2012;14:315-24.
  25. Saidani M, Hammami S, Kammoun A, Slim A, Boutiba -Ben Boubaker I. Emmergence of carbapenem resistant OXA-48 carbapenemase-producing Enterobacteriaceae in Tunisia. J Med Microbiol 2012;61:1746-9.
  26. Khan A, Nordmann P. NDM-1-producing Enterobacter cloacae and Klebsiella pneumoniae from diabetic foot ulcers in India. J Med Microbiol2012; 61:454-6.
  27. Lipsky BA, Berendt AR, Cornia PB et al. 2012 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Treatment of Diabetic Foot Infections. Clin Infect Dis 2012;54:132-73.
  28. Société de pathologie infectieuse de langue française. Recommandations pour la pratique Clinique : Prise en charge du pied diabétique infecté. Med Mal Infect 2007;37:1-13.
  29. Prompers L, Schaper N, Apelqvist J et al. Prédiction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The Eurodiale Study.Diabetologia 2008;51:747-55.
  30. Leese G, Schofield C, McMurray B et al. Scottish foot ulcer risk score predicts foot ulcer healing in a regional specialist foot clinic. Diabetes Care 2007;30:2064-9
  31. Ince P, Kendrick D, Game F, Jeffcoate W.The association between baseline characteristics and the outcome of foot lesions in a UK population with diabetes.Diabet Med 2007;24:977-81.
  32. Wagner A, Reike H, Angelkort B. Highly resistant pathogens in patients with diabetic foot syndrome with special reference to methicillin resistant Staphylococcus Aureus infection. Dtsch Med Wochenschr 2001;126:1353-6.
  33. Ng LS, Kwang LL, Yeow SS, Tan TY. Anaerobic Culture of Diabetic Foot Infections: Organisms and Antimicrobial Susceptibilities. Ann Acad Med Singapore 2008;37:936-9.
  34. Richard JL, Sotto A, Jourdan N et al. Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers. DiabetesMetab 2008;34:363-9.
  35. Cabete J, Martins de Carvalho F, Moniz L et al. Microbiological profile and antibiotic susceptibility patterns of organisms isolated from diabetic foot ulcers in a Portuguese hospital. Rev Cir CardiotoracVasc 2011;18:53-60.
  36. Game FL, Boswell T, Soar C. Outcome of diabetic foot ulcers with and without Staphylococcus aureus (MRSA). Diabet Med 2003;20:30-1.